IMMUNOLOGY OF MULTIPLE SCLEROSIS

Control of Regulatory T Cell Development by the Transcription Factor Foxp3

Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187

Axonal transection in the lesions of multiple sclerosis

Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906

Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells

Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000

Use of a cDNA microarray to analyse gene expression patterns in human cancer

DeRisi, J. L., Penland, L., Brown, P. O., Bittner, M. L., Meltzer, P. S., Ray, M., Chen, Y.-W., Su, Y. A., & Trent, J. M. (1996) · Nature Genetics · doi:10.1038/ng1296-457 · Cited by 1,952

Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection

Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918

Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858

Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M. N., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,683

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667

MBP-PLP fusion protein-induced EAE in C57BL/6 mice

Kuerten, S., Lichtenegger, F. S., Faas, S., Angelov, D. N., Tary-Lehmann, M., & Lehmann, P. V. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.021 · Cited by 54

Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice

Nomura, T., Abe, Y., Kamada, H., Shibata, H., Kayamuro, H., Inoue, M., Kawara, T., Arita, S., Furuya, T., Yamashita, T., et al. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.015 · Cited by 54

Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis

Angerstein, C., Hecker, M., Paap, B. K., Koczan, D., Thamilarasan, M., Thiesen, H., & Zettl, U. K. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8270-0 · Cited by 53

Clinical Potential of Intravenous Neural Stem Cell Delivery for Treatment of Neuroinflammatory Disease in Mice?

Reekmans, K., Praet, J., Vocht, N. D., Tambuyzer, B. R., Bergwerf, I., Daans, J., Baekelandt, V., Vanhoutte, G., Goossens, H., Jorens, P. G., et al. (2010) · Cell Transplantation · doi:10.3727/096368910x543411 · Cited by 53

What Went Wrong? the Flawed Concept of Cerebrospinal Venous Insufficiency

Valdueza, J. M., Doepp, F., Schreiber, S. J., van Oosten, B. W., Schmierer, K., Paul, F., & Wattjes, M. P. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.31 · Cited by 53

Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases

Singh, A., Upadhayay, S., & Mehan, S. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00401-6 · Cited by 53

Partial MHC class II constructs inhibit MIF / CD 74 binding and downstream effects

Benedek, G., Meza‐Romero, R., Andrew, S. F., Leng, L., Burrows, G. G., BOURDETTE, D. N., Offner, H., Bucala, R., & Vandenbark, A. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201243162 · Cited by 53

A specific viral cause of multiple sclerosis: One virus, one disease

Lipton, H. L., Liang, Z., Hertzler, S., & Son, K. (2007) · Annals of Neurology · doi:10.1002/ana.21116 · Cited by 55

Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates with disparity in production of IL-17, but not nitric oxide

Miljković, D. M., Stošić‐Grujičić, S., Marković, M., Momčilović, M. B., Ramić, Z., Maksimović‐Ivanić, D., Mijatović, S., Popadic, D. M., Cvetković, I., & Mostarica‐Stojković, M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20883 · Cited by 53

Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity—Preliminary Study

Kacperska, M. J., Jastrzębski, K., Tomasik, B., Walenczak, J., Konarska-Król, M., & Glabinski, A. R. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0476-3 · Cited by 54

The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components

Alikunju, S., Muneer, P. M. A., Zhang, Y., Szlachetka, A. M., & Haorah, J. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.007 · Cited by 53

The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis

Kaushansky, N., Eisenstein, M., Zilkha‐Falb, R., & Ben‐Nun, A. (2009) · Autoimmunity Reviews · doi:10.1016/j.autrev.2009.08.002 · Cited by 53

αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell–related features

Held, K., Bhonsle, L., Siewert, K., Sato, W., Beltrán, E., Schmidt, S., Rühl, G., Ng, J. K. M., Engerer, P., Moser, M., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000107 · Cited by 56

Targeting the Nogo Receptor Complex in Diseases of the Central Nervous System

McDonald, C., Bandtlow, C. E., & Reindl, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794088326 · Cited by 53

Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS

Cheng, W. (2011) · Frontiers in bioscience · doi:10.2741/4010 · Cited by 53

Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells

Kim, T. W., Kim, Y., Jung, W., Kim, D. E., Keum, H., Son, Y., & Jon, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.019 · Cited by 53

Carvacrol ameliorates experimental autoimmune encephalomyelitis through modulating pro- and anti-inflammatory cytokines

Mahmoodi, M., Amiri, H., Ayoobi, F., Rahmani, M., Taghipour, Z., Ghavamabadi, R. T., Jafarzadeh, A., & Sankian, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.11.051 · Cited by 53

Resistance to Experimental Autoimmune Encephalomyelitis and Impaired T Cell Priming by Dendritic Cells in Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase Substrate-1 Mutant Mice

Tomizawa, T., Kaneko, Y., Kaneko, Y., Saito, Y., Ohnishi, H., Okajo, J., Okuzawa, C., Ishikawa-Sekigami, T., Murata, Y., Okazawa, H., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.869 · Cited by 52

PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption

Yun, H., Park, K., Kim, E.-C., & Hong, J. T. (2015) · Oncotarget · doi:10.18632/oncotarget.5205 · Cited by 54

Reduced thymic output and peripheral naïve CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS)

Haegert, D. G., Hackenbroch, J., Duszczyszyn, D. A., Fitz-Gerald, L., Zastepa, E., Mason, H., Lapierre, Y., Antel, J. P., & Bar‐Or, A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.12.007 · Cited by 53

Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies

Pasquini, M. C., Griffith, L. M., Arnold, D. L., Atkins, H. L., Bowen, J. D., Chen, J. T., Freedman, M. S., Kraft, G. H., Mancardi, G., Martinꝉ, R., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.03.012 · Cited by 52

Gaining entry to an uninflamed brain

Axtell, R. C., & Steinman, L. (2009) · Nature Immunology · doi:10.1038/ni0509-453 · Cited by 54

Role of glial cells in innate immunity and their role in CNS demyelination

Sriram, S. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.012 · Cited by 54

Preimplantation Factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model

Weiss, L., Or, R., Jones, R. C., Amunugama, R., JeBailey, L., Ramu, S., Bernstein, S. A., Yekhtin, Z., Almogi‐Hazan, O., Shainer, R., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.050 · Cited by 52

B-cell depletion with rituximab in the treatment of autoimmune diseases

Nielsen, C. H., Fassi, D. E., Hasselbalch, H. C., Bendtzen, K., & Hegedűs, L. D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1061 · Cited by 52

Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis

Robinson, A. P., Rodgers, J. M., Goings, G. E., & Miller, S. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107649 · Cited by 52

The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis

Hart, B. A. ‘., Jagessar, S. A., Haanstra, K. G., Verschoor, E. J., Laman, J. D., & Kap, Y. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00145 · Cited by 52

Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway

Liu, S., Zhang, M., Zhang, H.-J., Liu, F.-Z., Chu, R.-J., Zhang, G., & Zhu, L. D. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.05.010 · Cited by 52

Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection

Blom, K. G., Cuapio, A., Sandberg, J. T., Varnaitė, R., Michaëlsson, J., Björkström, N. K., Sandberg, J. K., Klingström, J., Lindquist, L., Russ, S. G., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02174 · Cited by 52

Engineering three-dimensional microenvironments towards in vitro disease models of the central nervous system

Yildirimer, L., Zhang, Q., Kuang, S., Cheung, J. C., Chu, K. A., He, Y., Yang, M., & Zhao, X. (2019) · Biofabrication · doi:10.1088/1758-5090/ab17aa · Cited by 54

Multiple Sclerosis as A Painful Disease

Kenner, M., Menon, U., & Elliott, D. G. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79013-x · Cited by 52

Recognition of self-peptide–MHC complexes by autoimmune T-cell receptors

Deng, L., & Mariuzza, R. A. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.08.007 · Cited by 53

The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis

Mcdole, J. R., Johnson, A. J., & Pirko, I. (2006) · Neurological Research · doi:10.1179/016164106x98125 · Cited by 52

Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction

Grigoriadis, N., Grigoriadis, S., Polyzoidou, E., Milonas, I. A., & Karussis, D. M. (2006) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.11.006 · Cited by 52

HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis

Mohme, M., Hotz, C., Stevanović, S., Binder, T. M. C., Lee, J.-H., Okoniewski, M. J., EIERMANN, T. H., Sospedra, M., Rammensee, H., & Martinꝉ, R. (2013) · Brain · doi:10.1093/brain/awt108 · Cited by 51

A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis

Shen, R., Deng, W., Li, C., & Zeng, G. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.015 · Cited by 51

Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis

Michel, L., Chesneau, M., Manceau, P., Genty, A., Garcia, A., Salou, M., Ngono, A. E., Pallier, A., Jacq-Foucher, M., Lefrère, F., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.09.011 · Cited by 51

Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future

Raphael, I., Webb, J., Stüve, O., Haskins, W. E., & Forsthuber, T. G. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.991315 · Cited by 51

Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms

Alexander, J. S., Zivadinov, R., Maghzi, A., Ganta, V. C., Harris, M. K., & Minagar, A. (2010) · Pathophysiology · doi:10.1016/j.pathophys.2010.04.002 · Cited by 51

Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective Ligands of the Cannabinoid Type 2 Receptor

Han, S., Zhang, F., Qian, H., Chen, L., Pu, J.-B., Xie, X., & Chen, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00227 · Cited by 51

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions

Costa, C., Martínez-Sáez, E. A., Gutiérrez-Franco, A., Eixarch, H., Castro, Z., Aznar, A. O., y Cajal, S. R., Montalbán, X., & Espejo, C. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599848 · Cited by 51

Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE)

Liu, B., Gu, Y., Pei, S., Yu, P., Chen, J., Pham, L. V., Shen, H., Zhang, J., & Wang, H. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.020 · Cited by 51

Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients

Biasi, S. D., Simone, A. M., Bianchini, E., Tartaro, D. L., Pecorini, S., Nasi, M., Patergnani, S., Carnevale, G., Gibellini, L., Ferraro, D., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948223 · Cited by 51

Pathogenic autoantibodies in multiple sclerosis — from a simple idea to a complex concept

Höftberger, R., Lassmann, H., Berger, T., & Reindl, M. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00700-2 · Cited by 56

Predicting multiple sclerosis disease progression and outcomes with machine learning and MRI-based biomarkers: a review

Yousef, H., Tortei, B. M., & Castiglione, F. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12651-3 · Cited by 56

EMMPRIN, an upstream regulator of MMPs, in CNS biology

Kaushik, D. K., Hahn, J. N., & Yong, V. W. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.018 · Cited by 51

Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis

Balashov, K. E., Aung, L. L., Vaknin‐Dembinsky, A., Dhib-Jalbut, S. S., & Weiner, H. L. (2010) · Annals of Neurology · doi:10.1002/ana.22136 · Cited by 51

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies

Melzer, N., & Meuth, S. G. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12195 · Cited by 50

Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases

Koboziev, I., Jones‐Hall, Y., Valentine, J. F., Webb, C. R., Furr, K. L., & Grisham, M. B. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000446 · Cited by 50

Pain in autoimmune disorders

Mifflin, K. A., & Kerr, B. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23844 · Cited by 50

Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis

Faigle, W., Cruciani, C., Wolski, W., Roschitzki, B., Puthenparampil, M., Ojer, P. T., Sellès‐Moreno, C., Zeis, T., Jelčić, I., Schaeren‐Wiemers, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00540 · Cited by 50

Linking phytosterols and oxyphytosterols from food to brain health: origins, effects, and underlying mechanisms

Jie, F., Yang, X., Wu, L., Wang, M., & Lu, B. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1867819 · Cited by 50

Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells

Cunnusamy, K., Baughman, E. J., Franco, J., Ortega, S. B., Sinha, S., Chaudhary, P., Greenberg, B. M., Frohman, E. M., & Karandikar, N. J. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.03.005 · Cited by 50

p150/95 (CD11c/CD18) Expression Is Required for the Development of Experimental Autoimmune Encephalomyelitis

Bullard, D. C., Hu, X., Adams, J. E., Schoeb, T. R., & Barnum, S. R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061016 · Cited by 50

Two discreet subsets of CD8 T cells modulate PLP91–110 induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice

Mangalam, A. K., Luckey, D. H., Giri, S., Smart, M. K., Pease, L. R., Rodriguez, M., & David, C. S. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.02.004 · Cited by 50

Effects of interferon-β on co-signaling molecules: upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-β treatment in patients with multiple sclerosis

Wiesemann, E., Deb, M., Trebst, C., Hemmer, B., Stangel, M., & Windhagen, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507081342 · Cited by 50

Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep–Wake Cycle Disorder

Alhusaini, M., Eissa, N., Saad, A. K., Beiram, R., & Sadek, B. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.861094 · Cited by 51

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions

Planas, R., Metz, I., Ortiz, Y. M., Vilarrasa, N., Jelčić, I., Salinas, G., Heesen, C., Brück, W., Martinꝉ, R., & Sospedra, M. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.218 · Cited by 49

Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis

Quintana, F. J., Yeste, A., Weiner, H. L., & Covacu, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.01.002 · Cited by 51

Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications

Gajate, C., & Mollinedo, F. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0215-055r · Cited by 51

The Contribution of Major Histocompatibility Complex Class II Genes to an Association with Autoimmune Diseases

Zakharova, M. Y., Belyanina, T. A., Av, S., Сергеевич, К. И., & Mamedov, A. E. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-4-4-12 · Cited by 49

Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients

Amoruso, A., Blonda, M., Gironi, M., Grasso, R., Di Francescantonio, V., Scaroni, F., Furlan, R., Verderio, C., & Avolio, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63282-3 · Cited by 46

Paraoxonase Role in Human Neurodegenerative Diseases

Reichert, C. O., Levy, D., & Bydlowski, S. P. (2020) · Antioxidants · doi:10.3390/antiox10010011 · Cited by 53

Macrophages and Autoantibodies in Demyelinating Diseases

Koike, H., & Katsuno, M. (2021) · Cells · doi:10.3390/cells10040844 · Cited by 49

Autoimmune CD4+ T Cell Memory: Lifelong Persistence of Encephalitogenic T Cell Clones in Healthy Immune Repertoires

Kawakami, N., Odoardi, F., Ziemssen, T., Bradl, M., Ritter, T., Neuhaus, O., Lassmann, H., Wekerle, H., & Flügel, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.69 · Cited by 49

Therapeutic anti‐integrin (α4 and αL) monoclonal antibodies: two‐edged swords?

González‐Amaro, R., Mittelbrunn, M., & Sánchez‐Madrid, F. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02225.x · Cited by 49

Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination

Seiwa, C., Yamamoto, M., Tanaka, K., Fukutake, M., Ueki, T., Takeda, S., Sakai, R., Ishige, A., Watanabe, K., Akita, M., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21196 · Cited by 50

Mini Review: Immune Response to Myelin-Derived Sulfatide and CNS-Demyelination

Halder, R. C., Jahng, A. K., Maricic, I., & Kumar, V. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9145-4 · Cited by 49

Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus

Xie, C., Alcaide, P., Geisbrecht, B. V., Schneider, D., Herrmann, M., Preissner, K. T., Luscinskas, F. W., & Chavakis, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051681 · Cited by 49

Hygiene hypothesis: Innate immunity, malaria and multiple sclerosis

Sotgiu, S., Angius, A., Embry, A., Rosati, G., & Musumeci, S. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.069 · Cited by 49

Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein–kinin system

Dutra, R. C., Moreira, E. L. G., Alberti, T. B., Marcon, R., Prediger, R. D., & Calixto, J. Β. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.06.002 · Cited by 48

Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance

Sun, Y., Cai, T., Shen, Y., Zhou, X., Chen, T., & Xu, Q. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.08.017 · Cited by 48

Fasudil Ameliorates Disease Progression in Experimental Autoimmune Encephalomyelitis, Acting Possibly Through Antiinflammatory Effect

Hou, S., Liu, C., Li, Y., Yu, J., Feng, L., Liu, Y., Guo, M., Xie, Y., Meng, J., Zhang, H., et al. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12002 · Cited by 48

Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis

Fissolo, N., Costa, C., Nurtdinov, R., Bustamante, M. F., Llombart, V., Mansilla, M. J., Espejo, C., Montalbán, X., & Comabella, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-139 · Cited by 48

Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler’s virus infection

Meagher, M. W., Johnson, R. R., Young, E. E., Vichaya, E. G., Lunt, S., Hardin, E. A., Connor, M. A., & Welsh, C. J. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.05.001 · Cited by 48

Photobiomodulation Induced by 670 nm Light Ameliorates MOG35-55 Induced EAE in Female C57BL/6 Mice: A Role for Remediation of Nitrosative Stress

Muili, K. A., Gopalakrishnan, S., Eells, J. T., & Lyons, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067358 · Cited by 48

Structural Transition in Myelin Membrane as Initiator of Multiple Sclerosis

Shaharabani, R., Ram-On, M., Avinery, R., Aharoni, R., Arnon, R., Talmon, Y., & Beck, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b04826 · Cited by 48

Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation

Zhang, H., Qi, Y., Yuan, Y., Cai, L., Xu, H., Zhang, L., Su, B., & Nie, H. (2017) · Scientific Reports · doi:10.1038/srep41887 · Cited by 48

Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients

Lutterotti, A., Hayward-Koennecke, H. K., Sospedra, M., & Martinꝉ, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640935 · Cited by 49

Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications

Chuang, S. T., Conklin, B., Stein, J. B., Pan, G., & Lee, K. (2022) · Nano Convergence · doi:10.1186/s40580-022-00310-0 · Cited by 48

Potential role of hydroxytyrosol in neuroprotection

Chen, C., Ai, Q., & Wei, Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104506 · Cited by 47

EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation

Wang, J., Qiu, Y., Marti, Z., Li, F., Wacker, M., Oldrati, P., Mühlenbruch, L., Jin, L., Zhang, H., Xu, W., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.046 · Cited by 52

Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression

Rizzo, R., Gentili, V., Casetta, I., Caselli, E., Gennaro, R. D., Granieri, E., Cassai, E., Luca, D. D., & Rotola, A. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.004 · Cited by 47

Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis

Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.513391 · Cited by 48

Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model

Pulli, B., Buré, L., Wojtkiewicz, G. R., Iwamoto, Y., Ali, M. Y. J., Li, D., Schob, S., Hsieh, K. L., Jacobs, A. H., & Chen, J. W. (2014) · Radiology · doi:10.1148/radiol.14141495 · Cited by 48

Interferon-γ Safeguards Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis

Chen, N., Wang, C., Zhang, J., Qu, L.-W., Liu, X., Lu, Y., Yang, W. C., Deng, J., Lorenz, D., Gao, P., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.019 · Cited by 50

The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III

Vojdani, A., Lambert, J., & Kellermann, G. H. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep064 · Cited by 47

Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation

Watanabe, M., Masaki, K., Yamasaki, R., Kawanokuchi, J., Takeuchi, H., Matsushita, T., Suzumura, A., & Kira, J. (2016) · Scientific Reports · doi:10.1038/srep38387 · Cited by 47

Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation

Acharya, S., Timilshina, M., Jiang, L., Neupane, S., Choi, D., Park, S., Lee, S. Y., Jeong, B., Kim, J., Nam, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26088-y · Cited by 47

Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration

Ji, Z., Wu, S., Xu, Y., Qi, J., Su, X., & Shen, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01881 · Cited by 47

Targeting VIP and PACAP Receptor Signalling: New Therapeutic Strategies in Multiple Sclerosis

Tan, Y., & Waschek, J. A. (2011) · ASN NEURO · doi:10.1042/an20110024 · Cited by 47

Genes, environment, and susceptibility to multiple sclerosis

Sotgiu, S., Pugliatti, M., Fois, M. L., Arru, G., Sanna, A., Sotgiu, M. A., & Rosati, G. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.015 · Cited by 47

Crossreactivity of a human autoimmune TCR is dominated by a single TCR loop

Sethi, D. K., Gordo, S., Schubert, D. A., & Wucherpfennig, K. W. (2013) · Nature Communications · doi:10.1038/ncomms3623 · Cited by 46

Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: Therapeutic window and receptor subtype mechanism

Wang, T., Xi, N.-N., Chen, Y., Shang, X.-F., Hu, Q., Chen, J., & Zheng, R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.029 · Cited by 46

Semaphorins 3A and 7A: potential immune and neuroregenerative targets in multiple sclerosis

Eixarch, H., Gutiérrez-Franco, A., Montalbán, X., & Espejo, C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.01.003 · Cited by 46

Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis.

Hedayatpour, A., Kashani, I. R., Pasbakhsh, P., Kafami, L., Atlasi, N., Mahabadi, V. P., Ghasemi, S., & Reza, M. (2013) · Europe PMC (PubMed Central) · Cited by 46

Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis

Buck, D., Albrecht, E., Aslam, M., Goris, A., Hauenstein, N., Jochim, A., Cepok, S., Grummel, V., Dubois, B., Berthele, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23749 · Cited by 48

Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis

Gonçalves, E. D., de Souza, P. S., Lieberknecht, V., Pedroso, G. S., Barbosa, R. I., Silveira, P. C. L., Pinho, R. A., & Dutra, R. C. (2015) · Autoimmunity · doi:10.3109/08916934.2015.1124425 · Cited by 46

Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell‐based therapy in experimental autoimmune encephalomyelitis

Wang, D., Li, S., Fu, J., Bai, L., & Guo, L. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.01.005 · Cited by 46

Immunopathogenesis of Multiple Sclerosis

Agrawal, S. M., & Yong, V. W. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79005-0 · Cited by 46

IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS

Awad, A. M., & Stüve, O. (2010) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000389940.92283.aa · Cited by 10

The Etiology of Multiple Sclerosis

Confavreux, C., Goudable, B., & Moreau, T. (1930) · New England Journal of Medicine · doi:10.1056/nejm193011202032116 · Cited by 14

Chapter 4 Immunology of Multiple Sclerosis

Martinꝉ, R. (2003) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70033-9 · Cited by 1

Which Immune Cells Matter? The Immunopathogenesis of Multiple Sclerosis

Broux, B., Stinissen, P., & Hellings, N. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013007453 · Cited by 41

Immunopathology of multiple sclerosis

Pak, F., Nafariyeh, T., Asghari, N., Shokrollahy, M., & Kokhaei, P. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1